--News Direct--
Contact DetailsProactive Canada
Proactive Canada
+1 604-688-8158
na-editorial@proactiveinvestors.com
View original content to download multimedia: https://newsdirect.com/news/cardiol-therapeutics-begins-phase-ii-study-of-cardiolrx-for-treatment-of-recurrent-pericarditis-119915921